Insider Sale by Schoenberg Mark (Chief Medical Officer)
Trade Summary
2 days ago, Schoenberg Mark, serving as Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 871 shares at $42.92 per share, for a total transaction value of $37,383.32. Following this transaction, Schoenberg Mark now holds 59,882 shares of URGN.
This sale represents a 1.43% decrease in Schoenberg Mark's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, September 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 2:37 PM ET, 1 day after the trade was made.
UroGen Pharma Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$42.92
Quantity
871
Total Value
$37,383.32
Shares Owned
59,882
Trade Date
2 days ago
SEC Filing Date
at 2:37 PM ET
Filed 1 day after trade
Discussion